Anne Phillips

Non-Executive Director at Vaccitech

Dr. Phillips is the Senior Vice President, Clinical, Medical & Regulatory Affairs for Novo Nordisk Inc., leading the drug development, clinical operations, medical, regulatory, health economics and outcomes research, and safety teams.

Dr. Phillips has more than 25 years of healthcare experience, including serving as Vice President of Clinical Development at GlaxoSmithKline. In that role, she led global and regional clinical teams supporting cardiovascular, metabolic, and oncology medicines and provided clinical leadership and partnership in the management of one of the company’s largest medicines. Her prior experience also includes tenures as Associate Professor and Chief of Infectious Diseases at Wellesley Central Hospital at the University of Toronto. Dr. Phillips currently serves on the Board of Directors for AMAG Pharmaceuticals and Trevena, Inc. Dr. Phillips is a Fellow of The Royal College of Physicians and Surgeons of Canada and received her M.D. from the University of Toronto and B.S. in Zoology from the University of Western Ontario.

Timeline

  • Non-Executive Director

    Current role